Skip to main content

Dek-Quin Side Effects

Generic name: clioquinol / hydrocortisone topical

Medically reviewed by Drugs.com. Last updated on Jun 13, 2023.

Note: This document contains side effect information about clioquinol / hydrocortisone topical. Some dosage forms listed on this page may not apply to the brand name Dek-Quin.

Applies to clioquinol/hydrocortisone topical: topical cream.

Serious side effects of Dek-Quin

Along with its needed effects, clioquinol/hydrocortisone topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking clioquinol / hydrocortisone topical:

Incidence not known

Other side effects of Dek-Quin

Some side effects of clioquinol / hydrocortisone topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to clioquinol / hydrocortisone topical: topical cream, topical kit, topical ointment.

General

There have been a few reports of rash, hypersensitivity, and thinning of the skin following use of this combination product.[Ref]

Local

Topical corticosteroids:

Frequency not reported: Burning, itching, irritation, dryness, folliculitis, blistering, peeling, redness, swelling, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria, irritation[Ref]

Dermatologic

Frequency not reported: Rash, bruising, skin thinning

Postmarketing reports: Erythema, urticaria, skin pain, skin exfoliation, underlying symptoms exacerbated, hair discolored[Ref]

Endocrine

Postmarketing reports: Hypothalamic-pituitary adrenal (HPA) axis suppression, cushingoid features, endogenous cortisol levels decreased, steroid withdrawal syndrome[Ref]

Hypersensitivity

Frequency not reported: Hypersensitivity[Ref]

Genitourinary

Frequency not reported: Glucosuria

Hematologic

Frequency not reported: Bruising

Ocular

Postmarketing reports: Cataract, glaucoma[Ref]

Musculoskeletal

Postmarketing reports: Growth retardation/weight gain delayed in children, osteoporosis[Ref]

Metabolic

Postmarketing reports: Obesity/weight increased, hyperglycemia[Ref]

Cardiovascular

Postmarketing reports: Hypertension[Ref]

More about Dek-Quin (clioquinol / hydrocortisone topical)

Patient resources

Other brands

Dermasorb AF

Professional resources

Other brands

Ala-Quin

Related treatment guides

References

1. Cerner Multum, Inc. "Australian Product Information."

2. (2017) "Product Information. Dermasorb AF (clioquinol-hydrocortisone topical)." Crown Laboratories

3. (2017) "Product Information. Ala-Quin (clioquinol-hydrocortisone topical)." Crown Laboratories

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.